Evidence map›Paper›PMID 17464285›Full record

ArticleThe EMBO journal2007

Splicing factors stimulate polyadenylation via USEs at non-canonical 3' end formation signals.

Sven Danckwardt, Isabelle Kaufmann, Marc Gentzel, Konrad U Foerstner, Anne-Susan Gantzert, Niels H Gehring, Gabriele Neu-Yilik, Peer Bork, Walter Keller, Matthias Wilm and 2 more

Open access · greenAbstract readComparative Study
In one paragraph

Article in The EMBO journal, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 88 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. RNA Degradation in Neurodegenerative Disease.Advances in neurobiology · 2018
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Sven DanckwardtDepartment of Pediatric Oncology, Hematology and Immunology, University of Heidelberg, Germany.
Isabelle Kaufmann
Marc Gentzel
Konrad U Foerstner
Anne-Susan Gantzert
Niels H Gehring
Gabriele Neu-Yilik
Peer Bork
Walter Keller
Matthias Wilm
Matthias W Hentze
Andreas E Kulozik
Heidelberg University · DEEuropean Molecular Biology Laboratory · DEUniversity of Basel · CHEuropean Molecular Biology Organization · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prothrombin (F2) 3' end formation signal is highly susceptible to thrombophilia-associated gain-of-function mutations. In its unusual architecture, the F2 3' UTR contains an upstream sequence element (USE) that compensates for weak activities of the non-canonical cleavage site and the downstream U-rich element. Here, we address the mechanism of USE function. We show that the F2 USE contains a highly conserved nonameric core sequence, which promotes 3' end formation in a position- and sequence-dependent manner. We identify proteins that specifically interact with the USE, and demonstrate their function as trans-acting factors that promote 3' end formation. Interestingly, these include the splicing factors U2AF35, U2AF65 and hnRNPI. We show that these splicing factors not only modulate 3' end formation via the USEs contained in the F2 and the complement C2 mRNAs, but also in the biocomputationally identified BCL2L2, IVNS and ACTR mRNAs, suggesting a broader functional role. These data uncover a novel mechanism that functionally links the splicing and 3' end formation machineries of multiple cellular mRNAs in an USE-dependent manner.

Indexed as

3' Untranslated RegionsBase SequenceComputational BiologyGene ComponentsHumansModels, BiologicalMolecular Sequence DataMutationPeptide FragmentsPolyadenylationProthrombinRNA 3' End ProcessingRNA-Binding ProteinsRNA InterferenceRNA Splicing3' Untranslated RegionsPeptide FragmentsProthrombinprothrombin fragment 2RNA-Binding Proteins

Identifiers

PMID17464285
PMCPMC1888663
OpenAlexW2009358412

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.